Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling
Snowball
1 other identifier
observational
602
1 country
1
Brief Summary
The primary objective is to use "network targeted sampling design" to detect active and/or undiagnosed cases of COVID-19 in the community and determine the spread or distribution of 1) active infection, and 2) past exposure. The hypothesis is that there are many undiagnosed and/or asymptomatic people in the community who may be unknowingly spreading the virus or have been exposed and have antibodies. We propose to implement respondent-driven sampling (RDS) which leverages effort on the part of seed or index cases to recruit contacts for participation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2020
CompletedFirst Posted
Study publicly available on registry
June 18, 2020
CompletedStudy Start
First participant enrolled
December 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2022
CompletedJune 6, 2024
November 1, 2021
1.6 years
June 17, 2020
June 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants with Active Infection
Number of participants with active COVID-19 infection
12 months
Number of Participants with Antibodies Indicating Past Exposure
Number of participants with antibodies indicating past exposure to SARS-CoV-2
12 months
Study Arms (1)
Participants
Participants completing COVID-19 testing
Eligibility Criteria
Adults (18+ years) in the community who have tested positive for COVID-19 or have been in close contact with someone who is known to be COVID-19 positive
You may qualify if:
- Positive COVID-19 test result -or- receipt of a coupon from a previous study participant
- Resident of Durham County (for seed participant only)
- Willing to undergo COVID-19 test nasopharyngeal swab for RT-PCR testing and blood draw for COVID-19 antibody testing
- Age 18+
- Speak and understand English
You may not qualify if:
- Currently receiving inpatient treatment for COVID-19
- Unable to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Margaret Pendzich
Durham, North Carolina, 27710, United States
Related Publications (2)
Pasquale DK, Welsh W, Olson A, Yacoub M, Moody J, Barajas Gomez BA, Bentley-Edwards KL, McCall J, Solis-Guzman ML, Dunn JP, Woods CW, Petzold EA, Bowie AC, Singh K, Huang ES. Scalable Strategies to Increase Efficiency and Augment Public Health Activities During Epidemic Peaks. J Public Health Manag Pract. 2023 Nov-Dec 01;29(6):863-873. doi: 10.1097/PHH.0000000000001780. Epub 2023 Jun 28.
PMID: 37379511RESULTPasquale DK, Welsh W, Bentley-Edwards KL, Olson A, Wellons MC, Moody J. Homophily and social mixing in a small community: Implications for infectious disease transmission. PLoS One. 2024 May 28;19(5):e0303677. doi: 10.1371/journal.pone.0303677. eCollection 2024.
PMID: 38805519RESULT
Biospecimen
Blood and pharyngeal swabs
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dana Pasquale, PhD
Duke University
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2020
First Posted
June 18, 2020
Study Start
December 11, 2020
Primary Completion
July 25, 2022
Study Completion
July 25, 2022
Last Updated
June 6, 2024
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share